$AMBQ

Chen Timothy sold $1.7M of AMBQ (indirect holdings)

Chen Timothy sold 20,666 indirectly-held shares of Ambiq Micro, Inc. (AMBQ) at $80.61 ($1.67M total) on 2026-05-27.

Original reporting
SEC EDGAR · Chen Timothy
Published May 29, 2026, 11:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 11:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBQ
Neutral
medium confidence
Mentioned
$AMBQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

The disclosed sale may slightly pressure sentiment, but it is not a fundamental catalyst and typically has limited predictive power absent corroborating news.

02

Market read

Traders may monitor for follow-on insider activity, but the event alone is unlikely to drive a sustained repricing.

03

What to watch

The filing does not specify tax, diversification needs, or whether other insiders are buying; absence of a 10b5-1 plan can increase noise rather than signal.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed May 29 (transaction dated May 27)

Background

The article is an SEC Form 4 insider transaction disclosure for Ambiq Micro, Inc.

Company-level read

Ticker impact

$AMBQNeutralMedium confidence
Context

Ambiq Micro director Chen Timothy sold 20,666 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Likely small, short-lived impact; any effect should fade unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is an ownership-change disclosure with no 10b5-1 plan and includes sale size/price, but it does not reveal earnings, guidance, or business developments.

Market effects

Minimal; this is company-specific insider activity without sector-wide read-through.

None indicated.

None indicated.

Counterpoint

A director’s sale can be routine liquidity/portfolio rebalancing and may not reflect negative expectations, especially without any accompanying fundamental change.

Key entities

  • Ambiq Micro, Inc.

    Subject of the insider transaction disclosure; director Chen Timothy sold shares.

  • Chen Timothy

    Director who executed the open-market sale disclosed on Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.